Premier R&D service provider for the life sciences industry.
Joined August 2016
- Tweets 814
- Following 129
- Followers 431
- Likes 54
753 Photos and videos
Jun 11
Advanced imaging. Surgical research. FDA and EMA support. Discover Pharmaron’s full preclinical capabilities.
pharmaron.life/3YmO4MU
#Pharmaron #GLPTesting #Innovation
12
Jun 9
With Pharmaron’s infusion expertise, researchers maintain consistent drug levels for precise studies. Discover our PK services:
pharmaron.life/4fCwsCH
#Pharmacokinetics #drugdevelopment #Pharmaron #infusiontherapy #DrugDelivery
ALT Pharmaron promotional graphic featuring a gloved scientist filling a vial with a syringe, emphasizing controlled infusion for steady-state pharmacokinetics.
15
Jun 9
At Pharmaron, we understand the complexity of developing ocular medical devices—and we’re here to help you navigate it with confidence.
Learn more: pharmaron.life/4rUUvUG
11
Jun 9
20 years of kinase expertise. From hit ID to clinical candidate, Pharmaron accelerates discovery every step of the way.
#Pharmaron #kinase #drugdiscovery
ALT Flyer for Pharmaron's Kinase Drug Discovery services, featuring a QR code, URL, and images of lab scientists. Services listed include hit ID, kinase activity, panels, binding assays, CRISPR screening, signaling pathways, and phospho-proteomics. Tagline: "Driven by Science. Pharmaron."
7
Jun 4
Are your preclinical studies compliant? Get clarity on in vivo testing requirements in our new webinar.
pharmaron.life/42XnStK
#Pharmaron #Compliance #PreclinicalResearch
16
Jun 2
Revolutionizing drug metabolism studies—multiplex SILAC with CYP induction for smarter screening.
#MetaboliteProfiling #SILAC #PharmaronInnovation
Download the poster: pharmaron.life/4oUczf2
ALT Scientist analyzes data on dual monitors beside mass spectrometer, showcasing SILAC method for detecting trapped reactive metabolites.
34
Jun 2
At Pharmaron, we provide 𝐆𝐋𝐏-𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐭 𝐨𝐜𝐮𝐥𝐚𝐫 𝐭𝐨𝐱𝐢𝐜𝐨𝐥𝐨𝐠𝐲 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 designed to support the safety evaluation of ophthalmic products—from small molecules and biologics to gene therapies and ocular devices.
Learn more: pharmaron.life/3Msspjb
35
Jun 2
Download our poster that showcases how #PDXO 3D tumor #organoids enable rapid, reliable, high‑throughput #ADC screening : including a #HER2‑targeted case study.
Poster: ADC Efficacy and Safety Evaluation Based on Organoid Models. Download to learn more : pharmaron.life/4wig83j
39
Jun 1
Pharmaron's Dir. of Ophthalmology, Sandeep Kumar, will be presenting in this BioInnovate webinar.
𝐀𝐠𝐞𝐧𝐝𝐚
Session 1-Retinoblastoma: Searching or Novel Therapies
Session 2-Preclinical Ocular Melanoma Program: Insights from Animal Models
Register: pharmaron.zoom.us/webinar/re…
29
May 29
Pharmaron is proud to have sponsored the NEDMDG Summer Symposium again this year! Our team enjoyed reconnecting with familiar faces, meeting new scientists, and discussing innovation and collaboration. Thank you, NEDMDG, for organizing such a great event! #NEDMDG #Pharmaron #DMPK
1
23
May 28
Why use cadaver studies? Because human anatomy provides insights animal models can’t.
pharmaron.life/4jwTM7d
#Pharmaron #BioSkills #DeviceDevelopment
18
May 26
Pharmaron is proud to sponsor the NE DMDG 2026 Summer Symposium. Our local team will be at Ginkgo Bioworks in Boston tomorrow, May 27th. Meet our team to discuss your upcoming projects and learn how we can support your success!
60
May 26
With over 140 studies reviewed, Pharmaron demonstrates robust execution of radiolabeled mass balance studies aligned with FDA guidance.
#MassBalance #Radiolabeling #PharmaronDMPK
Download the poster: pharmaron.life/4nHWYOW
ALT Scientist wearing purple gloves handles a vial from a tray of blue-capped vials, supporting 14C AME studies as the gold standard.
14
May 26
Dr. Arun Singh, Director of the Department of Ophthalmic Oncology at Cleveland Clinic, is our guest speaker for our next BioInnovate webinar on 𝐉𝐮𝐧𝐞 𝟑 at 𝟏𝟏𝐚𝐦 𝐄𝐓.
Register for this webinar here: pharmaron.life/4v8haNP
30
May 26
Understanding how a compound behaves in the eye is critical to developing safe and effective ophthalmic therapies. At Pharmaron, our Ocular PK & Biodistribution Services provide the insights you need to move forward with confidence.
Learn more: pharmaron.life/4iSLabG
14
May 26
Pharmaron accelerates oncology drug discovery with 1,700 tumor models, advanced imaging, immune profiling & biomarker tech. From xenografts to CRISPR in vivo screening, we deliver fast, reliable, reproducible data with short study lead times. Learn more: pharmaron.life/4faCSMk
22
May 26
Pharmaron’s local team is excited to attend the Yale Innovation Summit on May 27–28. We’ll be on-site sharing how our capabilities support innovators, founders, and life science leaders to drive new ideas and breakthrough technologies. If you’ll be there, we’d love to connect!
15
May 25
Revolutionize your drug discovery workflow with the Explorer G3 suite.
Automated for biochemical & cell-based assays, with high-content imaging like cell painting—processing up to 200 plates/day.
#DrugDiscovery #HTS #Automation #Pharmaron #Biotech
ALT Scientist in lab coat monitors high-throughput screening system from a computer station in a clean, enclosed automation suite.
36
May 21
Accelerate EP device development with clinically relevant models and advanced testing tools.
pharmaron.life/4jwTM7d
#Pharmaron #Ablation #PreclinicalTesting
15
May 19
When is infusion the best dosing choice? Find out in our new flyer on pharmacokinetics in animal studies.
[pharmaron.life/4hFRcvm]
#DrugDevelopment #Pharmaron
15